Abstract:Niraparib is an anti-cancer drug marketed as a tosylate monohydrate salt (brand name ZEJULA). Although it was approved by USFDA and the European Union in 2017, niraparib tosylate is known to exist in only three solid forms till today. Amongst the three, the monohydrate is a stable form and the other two (anhydrous and non-stoichiometric hydrate) forms are quite unstable. Despite niraparib's potential value as a cancer treatment drug, there are currently very limited or no scientific reports on its solid form landscape. In this regard, this molecule has been chosen as a potential candidate for our research to find alternative solid forms that suite the early entry opportunity in the US or other generic markets. In this study, we initially investigated the reasons for the unstable nature of niraparib tosylate polymorphs other than its monohydrate. Further, we successfully synthesized a novel multicomponent solid form of niraparib tosylate with L -proline (NIR·TOS·PRO). Interestingly, the new multi-component solid is a "zwitterionic salt–cocrystal". To the best of our knowledge, this is the first case study reporting a zwitterionic salt–cocrystal. Preliminarily, the salt–cocrystal was characterized using powder X-ray diffraction and differential scanning calorimetry. Further, we carried out the structural elucidation for niraparib tosylate monohydrate as well as the new salt–cocrystal using single-crystal X-ray diffraction. The new salt–cocrystal was subjected to powder dissolution studies at pH 1.2, pH 4.5, and pH 6.8 to compare with the marketed form, "niraparib tosylate monohydrate (NIR·TOS·H 2 O)". Six-month stability studies were also performed according to the ICH guidelines. The solubility of NIR·TOS·PRO is found to be the same as that of the marketed form, which is an advantage in meeting the criteria of bioequivalence with RLD (reference listed drug), essentially to obtain the regulatory approval for US or other generic markets.

Design of Pyrazine Cocrystals of Enzalutamide –a lead from 1, 4-dioxane Solvates

Novel Pharmaceutical Cocrystal of Apalutamide, a Nonsteroidal Antiandrogen Drug: Synthesis, Crystal Structure, Dissolution, Stress, and Excipient Compatibility

Pharmaceutical Cocrystals of Ethenzamide: Molecular Structure Analysis Based on Vibrational Spectra and DFT Calculations

The supramolecular synthon behavior within cocrystals of pyrazinamide and alkyl dicarboxylic acids: A perspective from terahertz spectroscopy and quantum chemical calculation

A co-crystal strategy for the solidification of liquid pyrazine derivatives: X-ray structures and Hirshfeld surface analyses

Pharmaceutical Cocrystals: A Novel Systematic Approach for the Administration of Existing Drugs in New Crystalline Form

Amorphous solid dispersions of enzalutamide and novel polysaccharide derivatives: investigation of relationships between polymer structure and performance

Exploring the formation and diversity of secnidazole cocrystals

The Impact of Polymers on Enzalutamide Solid Self-Nanoemulsifying Drug Delivery System and Improved Bioavailability

Intravenous Delivery of Enzalutamide Based on High Drug Loading Multifunctional Graphene Oxide Nanoparticles for Castration-Resistant Prostate Cancer Therapy

A comparative study on in vitro and in vivo characteristics of enzalutamide nanocrystals versus amorphous solid dispersions and a better prediction for bioavailability based on "spring-parachute" model

Cocrystals of carbamazepine: Structure, mechanical properties, fluorescence properties, solubility and dissolution rate

Insights from NOESY NMR Analysis and Quantum-Chemical Calculations

Enhanced Stability and Improved Oral Absorption of Enzalutamide with Self-Nanoemulsifying Drug Delivery System

Investigation of Poor Solubility of a Salt-Cocrystal Hydrate: A Case Study of the Common-Ion Effect in Betrixaban, an Anticoagulant Drug

Cocrystal screening of benznidazole based on electronic transition, molecular reactivity, hydrogen bonding, and stability

A Drug–Drug Cocrystal Strategy to Regulate Stability and Solubility: A Case Study of Temozolomide/Caffeic Acid

A zwitterionic salt–cocrystal: in vitro insights from niraparib tosylate, an anti-cancer drug

Synthesis and structural characterization of two novel olanzapine cocrystals with decreased or enhanced dissolution rate

Insight into the Formation of Cocrystal and Salt of Tenoxicam from the Isomer and Conformation

A novel route for the synthesis of androgen receptor antagonist enzalutamide